Search
Artelo Biosciences Inc
ARTLAdd to Watchlist
0.663USD
+0.002+0.30%
Close 08-28 16:00（ET）
2.78MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-28The current earnings forecast score of Artelo Biosciences Inc is 6.00, ranking 322 out of 377 in the Biotechnology & Medical Research industry. The average price target is 30.00, with a high of 30.00 and a low of 30.00.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
30.000
Target Price
+471.43%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Artelo Biosciences Inc
ARTL
1
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
Kymera Therapeutics Inc
KYMR
24
IQVIA Holdings Inc
IQV
24
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Artelo Biosciences Inc's price target?
Analysts forecast that Artelo Biosciences Inc's price target is USD 30.00, with the highest forecast at USD 30.00 and the lowest forecast at USD 30.00.
What is the analyst rating for Artelo Biosciences Inc?
Based on the ratings of Artelo Biosciences Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.